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Just whose quality of life is it anyway? Controversies and or differences between levels of coping in patients under-
consistencies in measurements of quality of life. The proper going different medical treatments. Recent work has fo-
means of measuring quality of life (QOL) in patients with renal cussed on using measures of QOL as outcomes in them-disease, including end-stage renal disease, have not been agreed
selves, as well as predictors of other outcomes. Orupon. QOL has health-related and non-health-related do-
clinicians and providers may wish to improve patients’mains. QOL measures may be subjective or objective, function-
based or satisfaction-based, non-specific or applied to a particu- evaluations of their QOL. Interestingly, little attention
lar disease. Domains of health-related QOL typically include has been devoted to the development of interventions
measures of physical functioning, mental health, and social
designed primarily to improve perception of patients’relationships. There is increasing interest in measures of happi-
QOL.ness or global satisfaction in patients and in assessing how
patients’ feelings reflect their relationships with caregivers. An additional issue has been the measurement of
There are advantages and disadvantages to the use of older QOL in patients with chronic illness, rather than in gen-
psychologically based measures as QOL indicators as well as eral populations. Original descriptions of QOL were de-
newer questionnaires such as the Kidney Disease Quality of
veloped in an attempt to categorize the US experienceLife (KDQOL) Instrument. Challenges for the future include
as perceived by different groups of people, at differentcorrelation of QOL measures with patient biochemical and
disease measures, and with meaningful patient outcomes. Most stages of life [2]. Notions of QOL have extended from
important, we must create and apply methods to enhance our a general but comprehensive focus, to one related to the
patients’ QOL. experience of illness, sometimes categorized as Health-
related Quality of Life (HRQOL). This review will focus
on some of the most common QOL evaluators used in
The conceptual and theoretical bases for, and the patients with end-stage renal disease (ESRD) treated
proper means of measuring, quality of life (QOL) in with chronic maintenance hemodialysis (HD). It should
chronically ill patients remain incompletely defined [1]. not be taken, however, as comprehensive, and only a
Although it has generally been agreed that such mea- subset of the large literature will be directly cited. Several
sures must assess several and diverse aspects of peoples’ previous reviews however, provide a comprehensive bib-
experience, the practical issues regarding evaluation of liography through 1997 (cited in [3]). I will concentrate
patients’ QOL remain controversial and undetermined. on aspects of the commonly used measures to assess
The use of such measures may also be quite variable. QOL in HD patients. I will not review in depth the
Clinicians may desire these assessments to gauge the literature on erythropoietin and assessment of QOL, as
present status of a patient or patients. Payor organiza- this will be touched on by another contributor. I will
tions may wish to evaluate patients’ satisfaction with make a case for the use of multiple, well developed scales
care, or differences in levels of perceived satisfaction
to capture psychologically validated and generalizable
between patients treated in several medical organiza-
aspects of patients’ experiences, rather than the use of
tions. Researchers may wish to evaluate patients’ percep-
disease-specific scales to standardize measurements oftions of the effects of a therapy. Physicians may want to
HD patients’ QOL.quantify the adjustment of patients to a medical regimen,
In the United States, during the 1960s and early 1970s,
chronic dialysis was perceived as a heroic but intrusive
technological advance that allowed patients otherwiseKey words: hemodialysis, chronic kidney disease, depression, social
support, effects of illness. doomed to death to survive. Clinicians, policymakers,
and patients could agree that whatever the problems 2000 by the International Society of Nephrology
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Table 3. Quality of life categoriesTable 1. Types of quality of life measures
Domains Satisfaction/functionObjective vs. Subjective
Function-based vs. Satisfaction-based Health related quality of life
Disease-based vs. Non-specific Functional status F
Intrusive effects of illness S/F
Affective functioning S/F
Social functioning F/S
Table 2. Domains of quality of life Global satisfaction S
Employment F
Physical functioning Leisure F/S
Mental health Marital satisfaction F/S
General affect (mood) Sexuality F/S
Perception of well-being (illness effects) Spirituality S/F?
Life satisfaction (happiness)
Social relationships
review of assessment of QOL in patients with ESRD
with the treatment, it provided a clear and attractive categorized QOL into measurements of functional sta-
alternative to the inevitable. After the enactment of fed- tus, health status, well-being and patient satisfaction [3].
eral legislation making ESRD therapy available on a Original assessments of QOL in normative populations
wider basis, the number of patients in the U.S. ESRD included evaluations of housing conditions, employment
program rapidly burgeoned [4]. Pioneering studies of status, education and finances [2]. Although these are
QOL of patients treated with different modalities of often considered measures of socioeconomic status, such
renal replacement therapies by Simmons et al [5] deline- issues can impact upon patients assessments of QOL,
ated that most patients had perceptions of QOL that and perhaps their HRQOL.
were comparable with, if perhaps lower than normative
In previous studies, our group in Washington DCpopulations, but that a functioning renal transplant was
(composed of George Washington University Medicalassociated with perception of a higher QOL than in the
Center, Howard University Medical Center and the Vet-general population. Conversely, a failed transplant was
erans Affairs Medical Center) has favored the use of aassociated with worsened perceptions of QOL. ESRD
wider gamut of measures, structuring the domains ofcare over the past decades has been extended from pa-
HRQOL along several dimensions that have beentients with relatively few comorbid illnesses to an aging
gauged by psychological tests that are in wide use incohort of patients in which almost half the members
both general and ill populations (Table 3) [11].have diabetes mellitus [4]. As renal replacement therapy
It is important to start any discussion of QOL assess-has developed [6] and the patient population has ex-
ments with a definition of terms. These definitions arepanded, questions regarding the relationship of type,
taken in part (with slight modifications) from the usefulquality and duration of treatment to outcomes, including
survival and patient satisfaction, have been raised [3]. review of Gill and Feinstein [1]. An item is a single
Concern regarding the demographics, costs and mortal- question used to evaluate QOL. A scale is a way in which
ity in the program, coupled with a perception that the to present the responses to questions. A domain is the
elderly were not experiencing consonant benefits [7, 8], focus of attention of an item (such as happiness, or func-
led to renewed and invigorated interest in the assessment tional capacity). An instrument or index is a collection
of QOL in patients with ESRD. of items, which can vary in number from one to many.
Questions that are fundamental to issues to relevance Instrument components may be cited individually, as
of HRQOL measures include: 1) Does the way a person profiles or subscales; or, components can be cited in ag-
feels about him- or herself, family and friends, or the gregate as a score. Alternatively instrument components
way the illness affects him or her, have an impact on can be cited in both manners, as subscales and aggregate
outcome in patients with chronic medical illness? and, scores.
2) Does the manner in which a person reacts to the
Gill and Feinstein [1] have emphasized the utility ofillness within the medical community have an impact
assessing QOL, especially in research studies, by usingupon outcome in patients with chronic medical illness?
more than one instrument simultaneously in the sameA plethora of measurement tools of various kinds and
investigation, in order to provide a more comprehensiveutilities has been used in various populations to assess
focus to the meaning of a particular QOL indicator. TheyQOL [1]. QOL instruments may be objective or subjec-
have also advocated the use of a particular instrument,tive, satisfaction-based of function-based, or be disease-
possibly composed of a single item, in which the subject isor organ-based rather than non-specific (Table 1) [9].
specifically asked to rate his or her perception of currentAnother categorization divides HRQOL into physical,
mental and social dimensions (Table 2) [10]. A recent quality of life, presented using that specific phrase [1, 12].
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MEASUREMENT TOOLS Low correlations have been delineated between IWB
and IGA and Sickness Impact Profile (SIP) Physical Di-Probably the most widely used measure of HRQOL
mension and total scores (see below), and other func-in patients with ESRD treated with HD is the Karnofsky
tional scores, leading some to suggest these measures doPerformance Status Scale ([13–17] and reviewed in [10])
not capture the totality of HRQOL [10]. We too haveto quantify an individual’s level of functioning [13]. It is
shown that satisfaction with life scores (a global, subjec-composed of 11 qualifying statements, ranging from a
tive measures of QOL) correlated with advancing agescore of 100 for normal function, to zero for death, with
and increased severity of illness, but were not correlatedmarkers for requiring assistance at different levels, need-
with Karnofsky scores [11, 21, 22]. Global, subjectiveing custodial care, and needing hospital care. Higher
satisfaction with life can be assessed in patients withscores indicate better functional status. Originally de-
ESRD, and is related to subjective factors other thansigned as an objective scale for measuring function in
objective physical function as assessed by the medicalpatients receiving cancer chemotherapy, the Karnofsky
staff on the Karnofsky scale. Rather, satisfaction with lifeScale has been used in many different disease settings.
is significantly related to better subjective evaluations, asIt can be used as a subjective scale, when given to patients
assessed by the patient in a perception of illness scalefor their own assessments of their functional status. We
(IEQ) (see below). Specifically, Karnofsky ratings, anhave used this scale in a modified format for subjective
objective functional measure of quality of life, correlatedassessments, truncating it at a level of 40 (Disabled; re-
with relatively few parameters of patient perception wequires special care and assistance). We have also used
assessed. These results indicate to us the dissociationthe Karnofsky Scale to compare the assessments of pa-
of feelings of well-being from functional assessments intients and spouses (cited in [11]), which were different.
patients treated with HD [9], and emphasize the impor-Caveats have been raised regarding the reproducibility
tance of individual perception, rather than family or care-and interater reliability of the scores [18]. However,
giver assessments in determining functional quality ofmany studies of chronic HD patients have demonstrated
life. Such data lend credence to the recent consensusmean scores in the range of 70–80, indicating a level
forming that the patients’ subjective assessments areof functioning between being able to perform normal
more important in evaluating care than “objective” mea-activity with effort (80) and maintaining the ability to
sures [9]. Our data, however, would support the notioncare for oneself but being unable to carry on normal
that elderly patients treated with HD perceive them-activity or do active work (70). Comorbidity scales and
selves as having a good quality of life.symptom checklists have also been used to enhance the
Interestingly, several domains of quality of life in-utility and the subjective dimensions of functional assess-
crease dramatically with age in the general populationments [10].
in the United States [2]. Satisfaction with health status,Campbell et al [2] pioneered the field by surveying
in contrast, decreases with age in the general population,the perception of quality of life regarding numerous do-
as might be expected [2]. Our findings in a chronicallymains in large samples of Americans of different ages
ill population, however, are in agreement with the dataand backgrounds. Measures of general well-being have
from a “well” population, suggesting that older HD pa-been derived from these scales, and used in patients with
tients have greater perceived satisfaction with life regard-ESRD ([4, 11, 16, 19] and reviewed in [10]). The Index
less of the severity of illness, and with the work of Kutnerof General Affect measures how the subject feels about
et al [23], who showed elderly African American HDlife, ranging from extremes of satisfaction to dissatisfac-
patients, in particular, had greater satisfaction with lifetion. The Index of Life Satisfaction is a single item deal-
compared with white patients. SWLS scores, regardlessing with satisfaction with life on a scale from 1 to 7. The
of age, in our studies were correlated with depression,Index of Well-being score is derived from a combination
perception of illness, social activities, presence of a rela-of the two scales. High scores signify high satisfaction.
tionship and social support.The scores exhibited good psychometric properties in
Depressive affect should not be confused with theESRD patients [10, 19].
diagnosis of clinical depression [24]. Measures of de-The Satisfaction with Life Scale (SWLS) [20] is a five-
pressive affect are included in many QOL indices (re-item scale with a 1 to 7 satisfaction rating for each item,
viewed in [10]). The prevalence of depression has variedwhich we have used extensively [11, 21, 22]. The items
impressively between studies of patients with ESRDask about ideal life, conditions of life and satisfaction
treated with HD at different times and in different loca-with present and past life. The scale exhibits good psy-
tions [24]. One problem may be the confounding of thechometric properties [20] and correlations of 0.50–0.60
somatic characteristics of depression with uremic symp-with other subjective well-being scales. Higher scores
toms [24]. A critical issue with adherents on both sidesindicate higher satisfaction. We have used the SWLS in
is whether depression is independently associated withour studies as a general global, subjective quality of life
measure [11, 21, 22]. mortality in patients treated with HD [24].
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Probably the most widely used measure of depression and special persons) were averaged to form a total sup-
port score (MSP) [11]. In studies in HD patients thesein patients with ESRD treated with HD is the Beck
Depression Inventory (BDI) [10, 24, 25]. Use of the social support scores correlated with other support mea-
sures and depression [11].Center for Epidemiologic Studies Depression Scale [10]
has also been advocated in patients with ESRD and other The presence of a committed dyadic relationship and
marital satisfaction have been considered important fac-chronic medical illnesses. The BDI is a well-validated
measure of depression, which assesses somatic and cogni- tors is the assessment of QOL in the general population
[2]. They may be in fact most related to the conceptstive aspects of depression, such as fatigue and quality of
sleep function [25]. The BDI is composed of 21 items, of social support and satisfaction with life. However,
participating in a dyadic relationship and patients’ per-each scored on a 4-point Likert scale. Total scores can
range from zero to 63. Higher scores indicate greater ceptions of assessments of the quality of the relationship
may markedly influence quantification of other QOLlevels of depressive effect. The BDI provides cutoffs for
the diagnosis of depression, and therefore can be used domains. Our data suggest dyadic adjustment should be
viewed as a social support variable, rather than a qualityto estimate the incidence and prevalence of depressive
symptoms within populations. A score of 11–18 is associ- of life measure. The presence of a relationship correlated
with social support and weakly with a measure of behav-ated with mild depression, 19–25 with moderate depres-
sion, and 26 or more with severe depression, in patients ioral compliance [11]. How such determinants interact
with treatment parameters and outcomes is a matter ofwithout chronic medical illness. Scores of less than 11
suggest absence of clinical depression. The meaning of great interest. These factors may have quite different
interrelationships in men and women and in patients ofvery low scores (0–2) is not clear. It is necessary to
validate the results of an instrument measuring de- different ethnic backgrounds.
Intrusive effects of illness comprise the patient’s per-pressive effect with a clinical interview or a structured
diagnostic tool such as the Diagnostic Interview Sched- ception of how the disease state interferes with the
patient’s life. Interestingly, two patients with similarule [26], in order to establish the diagnosis of depression
in a patient. However, when assessed in such a rigorous medical characteristics (for example, blind, amputated
diabetic patients with ESRD who have sustained myo-manner, a score of 15 produced excellent sensitivity and
negative predictive values in a study of dialysis patients, cardial infarctions and numerous vascular surgeries) may
have very different perceptions of illness intrusiveness.distinguishing depressive symptoms from the presence
of a psychiatric disorder [27]. Such findings emphasize the dissociation of measures of
illness intrusiveness from functional status assessments,We derived and have used the Cognitive Depression
Index (CDI) [11, 21, 22, 24, 28, 29], a subset of the BDI, and their possible association with measurements of gen-
eral well-being, happiness, depression and social support.which focuses on the thoughts and feelings related to
the diagnosis of depression, such as guilt, disappointment Intrusiveness indices can assess the illness, its treatment
or overall perceptions. Two instruments have been de-and failure, excluding the items regarding somatic func-
tion. The CDI has previously been highly correlated with veloped and used in the majority of studies of patients
with ESRD to assess patients’ perceptions of illness in-the BDI, and perception of illness effects (IEQ) (see
below) in ESRD patients [11, 21, 22). Previously docu- trusiveness.
The Illness Intrusiveness Rating Scale (IRS) is a self-mented correlations suggested that the CDI is a better
measure of depression than the BDI in patients with report index which rates the extent to which the illness
interferes with 13 domains related to QOL [32]. HigherESRD [11].
The Affect Balance Scale has also been frequently scores indicate worsened perception of illness intru-
siveness. It has exhibited good psychometric propertiesused to assess depressive effect in patients with ESRD
(reviewed in [10]). It is composed of two scales: the in patients with ESRD [10].
The Illness Effects Questionnaire (IEQ) [32, 33] as-Positive and Negative Feelings Scales, and has exhibited
good psychometric properties in studies of patients with sesses the individual’s perceptions of how the subject’s
illness interferes with or affects personal, physical, andESRD.
Social support is multidimensional information that an social behavior. It is a subjective, generic instrument.
Higher scores reflect a more negative perception. Theindividual is a member of a complex network of affection,
mutual aid, and obligation. The Multidimensional Scale IEQ has high test-retest reliability [32, 33] and high inter-
nal reliability [32, 33]. The IEQ is strongly correlatedof Perceived Social Support (MSPSS) is a twelve item
inventory of overall perceived social support, divided with depression in medical patients and patients with
ESRD [11, 21, 22, 33]. Several groups have advocatedinto three factor groups: social support from a special
person, family, and friends [30]. The MSPSS scale has the use of the IEQ as a QOL measure [33, 34].
Patients’ age, severity of illness, and serum albumindemonstrated good internal and test-retest reliability
[30]. In our studies the three subscales (family, friends, concentration did not correlate with our measured scale
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Table 4. Kidney Disease Quality of Life (KDQOL)of patients’ assessment of the effects of illness, the IEQ.
kidney-specific domains
IEQ scores reflecting worsened perceptions of the effects
Symptoms/problemsof the illness were also highly correlated with higher
Effects of kidney disease on daily lifelevels of cognitive depression, lower levels of perceived
Burden of kidney disease
social support, and worsened perception of satisfaction Cognitive function
Work statuswith life. Worsened IEQ scores and Karnofsky scores
Sexual functionwere weakly correlated in a large population of incident
Quality of social interaction
and prevalent HD patients [11]. Interestingly, this rela- Sleep
Social supporttionship did not hold in patients who had recently started
Dialysis staff encouragementESRD therapy [22]. The intercorrelations, however, sug-
Patient satisfaction
gest that the IEQ is an excellent measure of HRQOL.
The meaning of the IEQ may be slightly different in
incident compared with prevalent patients.
The Sickness Impact Profile (SIP) [35] is a subjective
manner to track ESRD patients’ perceptions over time
measure used to assess the effect of the illness on the
[39]. The SF-36 has also been used in ESRD patients
patient, designed to be non-disease-specific. There are
[40, 41] and to assess changes associated with provision136 statements regarding 12 activities. Subscale scores
of erythropoietin [42, 43]. Patients with ESRD treatedinclude a Physical Dimension, and a Psychosocial Di-
with HD had lower SF-36 scores compared with patientsmension, the latter including mental health and social
with other chronic diseases [44] and patients with Typerelations, and an overall score. Scores may range from
II diabetes mellitus in the Medical Outcomes Study [45],0–100 on subscale and total scales, with higher scores
but higher scores than patients with chronic obstructiveindicating poorer functional or psychosocial status. It
pulmonary disease and asthma.has been used about as frequently as the Karnofsky Scale
The Kidney Disease Questionnaire [46] represents anin patients with ESRD [10], and has been used in Euro-
early attempt to harness some of these disparate mea-pean studies of patients with ESRD [36, 37].
sures into a disease-focussed scale for specific use inThe RAND 36-Item Health Survey 1.0 (SF-36) is a
patients with renal disease. It is composed of five dimen-generic measure of HRQOL, designed by Dr. Ware and
sions: Physical Symptoms, Fatigue, Depression, Rela-colleagues for use in the Medical Outcomes Study [38].
tionships with Others and Frustration.It is a short form, composed of 36 items evaluating func-
The Kidney Disease Quality of Life (KDQOLe) In-tional status, well-being and perceptions of health status.
strument (dialysis version) [44] is a self report measureThe eight scales are scored from 0 to 100 and are: Physical
specifically developed for use with patients with ESRDFunctioning, Role Limitations due to Physical Health,
treated with HD. It is composed of 134 generic andBodily Pain, General Health Perception, Vitality, Social
kidney disease/dialysis specific items. It was developedFunctioning, Role Limitations due to Emotional Prob-
using focus groups consisting of patients and staff mem-lems, and Mental Health. Higher scores signify better
bers, and was tested on small samples of HD patientsperception of health. U.S. population means for the
[44]. Functioning and well-being are evaluated using, asscales vary from 61 to 84, and the norms can be adjusted
its basis, [47, 48] and additional scales to assess concernsfor age. A Physical Component Score (PCS) can be cal-
specific to dialysis patients (Table 4). These latter in-culated, and is an appraisal of Physical Functioning, Role
clude: a symptom/problem scale, an effects of kidneyPhysical, Bodily Pain, and General Health scores, with
disease on daily life scale, and an employment statusa transformed mean of 50, and a standard deviation of
evaluation. Items to assess cognitive function were de-10. The Mental Component Score (MCS) (calculated
rived from the SIP [35, 49]. Other scales were derivedfrom the Vitality, Social Functioning, Role Emotional,
from other instruments: a quality of social interactionand Mental Health subscales) has an identical trans-
scale, a sexual function scale, and items to assess sleep,formed mean and standard deviation. Therefore, for
social support and patient satisfaction [44]. Items createdthese summary scores of the SF-36, scores above 50 are
for the KDQOL assess patients’ perceptions of encour-above average and scores below 50 are below average.
agement by staff and their evaluation of their healthInterestingly, the questions comprising the vitality scores
status. Scale scores can be transformed linearly intoassess issues regarding fatigue and energy, and like many
0–100 point scores. Higher scores indicate more favor-depression scores, may be confounded by the medical
able perceptions. RAND scoring algorithms may be usedaspects of a patient’s illness [11].
to score the KDQOLe SF-36 items. The scales showThe SF-36 has several potential uses. It can provide
internal consistency and reliability [44]. A shorter form,descriptive information regarding populations, and can
the KDQOL-SFe (composed of 79 questions) was de-be used to compare populations. In addition, it can be
used in individual patients and has been used in this veloped because of concerns regarding the time it took
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to administer the KDQOLe [44]. The number of ESRD- Interestingly, the relationship between depressive af-
fect and survival has been extremely controversial inrelated and generic QOL items was markedly decreased.
Subsequent analyses suggested the scales comprise four studies of patients with ESRD. This may be a function
of the different definitions that have been used to assessdimensions. Physical health (composed of physical func-
tioning, work status, role limitations due to physical depression, and the variation in populations studied [11].
However, the analytic strategies for assessing the rela-health, general health perceptions, pain, energy), mental
health (emotional well-being, quality of social interac- tionship between depression and outcome have in gen-
eral been poorly controlled. Few studies have assessedtions, burden of kidney disease, social support, role limi-
tations due to emotional problems), kidney-disease is- the relationships of demographic factors, patient compli-
ance, nutrition, dose of dialysis delivered and psycho-sues (cognitive function, symptoms/problems, effects of
kidney disease on daily life, sexual function and sleep) neuroimmunologic function to outcome in research on
depressive affect in ESRD patients [24]. Recent evi-and patient evaluation of care (patient satisfaction and
perceptions of staff encouragement). Social functioning dence suggests longitudinal analyses may provide supe-
rior data [56].is related to both the domains of physical and mental
health [44]. Limited material in the KDQOLe is devoted Perceptions of social support have been linked to pa-
tient survival in almost every chronic illness in which itto the assessment of global satisfaction, marital adjust-
ment or social support. has been assessed [57]. Several studies have established
this as the case for patients with ESRD [55, 58–60]. AsThe use of the KDQOLe has increased remarkably
over the last several years. The KDQOL is being used outlined in a review article, the challenge is to understand
the mechanisms by which the experience of social sup-in the NIDDK-supported HEMO study. The HEMO
study reported on its first assessment of QOL parameters port is translated into improved survival. Candidates for
mediators include better access to health care, betterin a large group of patients enrolled during the initial
phases of the study [50]. The mean physical components compliance and better neurophysiologic or psychologic
functioning [57].score of the HEMO patients was lower than the national
We recently showed patients with lower perception ofaverage, but mean mental component scores were ap-
the intrusiveness of illness using the IEQ had improvedproximately equal to the U.S. norm. Interestingly, in our
patient survival in a population of incident and prevalentpopulation of HD patients, studied in Washington, DC,
patients with ESRD treated with HD, when the variationprimarily composed of African-American men, total and
in several demographic predictors, including age, medi-ESRD-related KDQOL scores were highly correlated
cal comorbidity, and serum albumin concentration waswith patients’ perceptions of both depressive symptoms
controlled [55]. The mechanisms underlying this associa-and the intrusiveness of illness effects, but not with social
tion are unclear, but may involve neurohumoral as wellsupport or Karnofsky scores [51].
as behavioral pathways [55, 57]. This association with
outcome, as well as its intercorrelations and lack of corre-
DO THESE MEASURES MATTER? lation with severity of illness make the IEQ a very attrac-
A critical issue for the measure of QOL is are these tive measure of QOL for use in patients with ESRD
assessments related to outcomes [52]? As the field ma- treated with HD.
tures, it is becoming increasing clear that these measures Socioeconomic status (SES) has consistently been as-
are related to important outcomes in patients with sociated with improved health outcomes in many popula-
ESRD. tions [61]. Few studies have assessed the domains of SES,
Functional status parameters have been shown by sev- and their association with QOL indicators and outcome
eral investigators [17, 53, 54] to predict hospitalization measures in patients with ESRD [62]. Intriguing prelimi-
and survival, when the variation in several demographic nary data suggest that these parameters operate differ-
predictors is controlled. However, it is to be noted that ently in different patient groups. More studies are neces-
functional scores are not correlated with satisfaction sary to assess these issues in the U.S. and in other ESRD
scores, are often not subjective, and are insufficient for populations.
making judgements regarding continuation of dialytic Finally, in a study of 79 ESRD patients treated with
therapy. HD, Julie Kovac in our group showed improved behav-
We were unable to show an association of our satisfac- ioral compliance and higher levels of serum albumin
tion with life scale and patient survival, although it was were associated with patients’ perceptions of their satis-
highly correlated with what we consider many QOL faction with nephrologists [63]. These patient percep-
scales [55]. Subjective, patient-centered satisfaction with tions of satisfaction with the physicians were not associ-
life measures may however be most useful to families ated with the severity of patients’ illnesses. Such findings
and care-givers in evaluating decisions to discontinue suggest the perceptions of patients regarding their physi-
cians may be associated with improved nutrition anddialysis treatments.
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